5Milisenda JC, Selva-O' Callaghan A, Grau JM. The diagnosis and classification of polymyositis [ J ]. J Autoimmun, 2014, 48-49: 118-121.
6Lega JC, Fabien N, Reynaud Q, et al. The clinical phenotype associated with myositis-specific and associated autoantibodies: A meta-analysis revisiting the so-called antisynthetasesyndrome [ J ]. Autoimmun Rev, 2014, 13(9) : 883-891.
7Mahler M, Miller FW, Fritzler MJ. Idiopathic inflammatory myopathies and the anti-synthetase syndrome: a comprehensive review[J]. Autoimmun Rev, 2014, 13(4-5): 367-371.
8Vmcsa A, Gergely L, Ponyi A, et al. Myositis-specific and myositis-associated antibodies in overlap myositis in comparison to primary dermatopolymyositis: Relevance for clinical classification: retrospective study of 169 patients[ J]. Joint Bone Spine, 2010, 77(2) : 125-130.
9Miranda SS, Alvarenga D, Rodrignes JC, et al. Different aspects of magnetic resonance imaging of muscles between dermatomyositis and polymyositis [ J ]. Rev Bras Reumatol, 2014, 54 (4) : 295- 300.
10Hoogendijk JE, Amato AA, Lecky BR, et al. ll9Th ENMC international workshop : trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, the Netherlands [ J ]. NeuromusculDisord, 2004, 14(5) : 337-345.
